2020
$96M
from 7 investors over 7 rounds
Cajal Neuroscience raised $96M on November 29, 2022
Investors: Lux Capital, Bristol-Myers Squibb, UK, Two Sigma Ventures, The Column Group, Dolby Family Ventures and Evotec
Cajal Neuroscience raised undisclosed on January 1, 2020
Investors: Lux Capital